Luxcel teams with Fusion Antibodies

CORK start-up biotechnology company Luxcel Bioscences has teamed up with Northern firm Fusion Antibodies to improve cancer detection and treatment, after the companies landed a €400,000 grant from cross-border business development agency InterTrade Ireland.

The money was made available under the Onnova programme, which funds research and development and facilities co-operation between companies on both sides of the border.